Ozempic maker says unapproved compounded drugs being sold in Canada

You can use your smart phone to browse stories in the comfort of your hand. Simply browse this site on your smart phone.

Using an RSS Reader you can access most recent stories and other feeds posted on this network.

SNetwork Recent Stories

Ozempic maker says unapproved compounded drugs being sold in Canada – GLOBAL

by tmnationtalk on July 30, 2024181 Views

July 30, 2024

Unapproved, compounded versions of a popular diabetes and weight-loss drug are being sold in Canada, the Ozempic maker said, amid a warning about dosing errors that have resulted in some people being hospitalized in the United States.

Novo Nordisk told Global News on Monday that it has filed a complaint with Health Canada regarding the promotion and sale of compounded semaglutide – which is a key ingredient in both Ozempic and Wegovy – in Canada.

“We are aware that several compounding pharmacies, weight loss clinics, and medical spas are purporting to sell or offer unapproved compounded semaglutide products both in Canada and the U.S.,” a spokesperson for Novo Nordisk Canada said in an emailed statement.

“Patients should be aware that Novo Nordisk is the only company in Canada with Health Canada-approved products containing semaglutide and the only company in the U.S. with FDA-approved products containing semaglutide, identified under the trade names Ozempic, Rybelsus and Wegovy.”